Business description: Sartorius AG

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.

Number of employees: 13,762

Sales by Activity: Sartorius AG

Fiscal Period: December20192020202120222023

Bioprocess Solutions

1.37B 1.78B 2.73B 3.33B 2.68B

Lab Products & Services

455M 553M 722M 848M 718M
See all business segments

Geographical breakdown of sales: Sartorius AG

Fiscal Period: December20192020202120222023

USA

571M 755M 1.06B 1.44B 1.16B

Other EMEA

453M 629M 967M 1.06B 883M

Other Asia Pacific

216M 234M 356M 412M 352M

Germany

189M 210M 318M 350M 304M

China

151M 224M 379M 471M 276M

South Korea

97.42M 130M 162M 198M 171M

France

91.54M 96.08M 126M 145M 129M

Other Americas

59.15M 56.95M 79.51M 102M 119M
See all geographic segments

Managers: Sartorius AG

Director TitleAgeSince
Chief Executive Officer 59 2004-12-31
Director of Finance/CFO 53 2024-03-31
Chief Operating Officer 68 2000-12-31
Chief Tech/Sci/R&D Officer 60 1994-12-31
Investor Relations Contact 56 2010-12-31
See SARTORIUS AG governance

Members of the board: Sartorius AG

Manager TitleAgeSince
Director/Board Member 61 2002-08-31
Chairman 67 2017-07-08
Director/Board Member 56 2010-09-30
Director/Board Member 76 2011-11-28
Director/Board Member 68 2014-02-28
Director/Board Member 61 2017-04-05
Director/Board Member 59 2017-04-05
Director/Board Member 70 2019-12-31
Director/Board Member 49 2020-05-15
Director/Board Member 59 2021-02-28
Composition of the Board of Directors

Shareholders: Sartorius AG

NameEquities%Valuation
9,588,908 25.61 % 2 142 M €
3,250,147 8.681 % 726 M €
Nordea Investment Management AB
0.2984 %
111,712 0.2984 % 25 M €
Juno Investment Partners
0.1449 %
54,237 0.1449 % 12 M €
State Street Global Advisors Ltd.
0.1380 %
51,654 0.1380 % 12 M €
NameEquities%Valuation
RhumbLine Advisers LP
0.000351 %
658 0.000351 % 29 326 €
NameEquities%Valuation
Armira Partners GmbH & Co. KG
50.09 %
18,754,160 50.09 % 3 356 M €
12,987,900 34.69 % 2 324 M €
3,213,991 8.584 % 575 M €
855,673 2.285 % 153 M €
Carmignac UK Ltd.
0.2450 %
91,714 0.2450 % 16 M €
List of SARTORIUS AG shareholders

Holdings: Sartorius AG

NameEquities%Valuation
71,635,17873.60%13,997,432,117 $
3,250,1478.68%726,045,008 $
7,123,62610.31%20,654,954 $

Company details: Sartorius AG

Sartorius AG

Otto-Brenner-Strasse 20

37079, Goettingen

+49 551 308 0

http://www.sartorius.com
address Sartorius AG(SRT3)

Group companies: Sartorius AG

NameCategory and Sector
Medical Specialties
Electronic Production Equipment
Medical Specialties
Medical Specialties
Medical Specialties
See all subsidiaries

Medical Diagnostic & Testing Equipment

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+3.27%+5.68%-16.22%-46.34%15.63B
+1.74%+10.45%-38.44%-57.64%2.94B
-0.78%-2.75%-13.66% - 1.15B
-0.92%-3.91%-10.92%+137.94%1.15B
+0.37%-0.07%-0.51%-26.13%996M
-1.40%+9.49%+16.21%-36.96%829M
-0.85%+2.30%-12.13%+9.26%788M
-1.89%-3.28%-28.95%-63.28%730M
-0.22%+2.44%-30.91%-50.04%574M
-8.41%-4.06%+7.65%-36.91%503M
Average -0.91%+4.39%-12.79%-18.90% 2.53B
Weighted average by Cap. +1.86%+5.46%-16.86%-36.36%
See all sector performances
Trading Rating
Investor Rating
ESG MSCI
surperformance-ratings-light-chart SARTORIUS-AGMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
249.40EUR
Average target price
262.90EUR
Spread / Average Target
+5.41%
Consensus

Quarterly revenue - Rate of surprise